In order to prevent and control the transmission risk of the Ebola virus, an Ebola virus disease SEIQR model was built. The free-Ebola-virus-disease equilibrium state and the Ebola-virus-disease equilibrium state of the SEIQR model are asymptotically stable. On the basis of the SEIQR model, the numerical simulation was formulated. From the simulation curves, it is found that if the production speed of the medicine cannot keep pace with demand, the transmission risk of Ebola will become out of control. Assuming that the medicine demand point and the medicine supply point constitute a logistics system in a certain planar range, the center-of-gravity method was used to obtain the optimal location for medicine delivery. By using this discrete-time virus model's optimal control rate to control the serious transmission risk of Ebola virus in the crowd, the effective strategy for transmission was added to the model, and then the control sheet was obtained. From the simulation results on the basis of the SEIQR model, it is concluded that the theory of the optimal control rate has a negative effect on the transmission risk of Ebola.
Introduction
The WHO reported that from 2014, an outbreak of the Ebola virus disease (EVD) began in the tropical regions of West Africa, especially in Guinea, Liberia, and Sierra Leone. By February 5, 2015, a total of 22,460 probable and confirmed cases, including 8966 deaths, had been reported from these countries. In terms of reported morbidity and mortality, the current epidemic of EVD is far larger than all previous epidemics combined. 1 Based on the number of patients in previous years, we forecast the incidence of EVD in the future. Data analyses prove that without operative control measures, the numbers of cases and deaths from EVD are expected to continue increasing drastically. If the speed of manufacture of the medicine needed cannot keep up with the transmission risk of the disease, there is no effective way to control the epidemic of EVD.
EVD is a viral hemorrhagic fever of humans and other primates caused by Ebola viruses. If the Ebola virus spreads in an uncontrolled fashion, many people will lose their lives. Therefore, it is necessary to control the transmission risk of EVD. Li presented a mathematical model to estimate the basic reproduction number in Sierra Leone, and found that if effective control strategies are not adopted, there would be an outbreak of EVD in Sierra Leone. 2 Durojaye and Ajie analyzed the transmission dynamics of EVD, and built a mathematical model to see the effect of vaccination on the spread and control of the disease. 3 Burkhead and Hawkins constructed a stochastic cellular automaton model for the spread of the EVD, and compared the output from the model and with clinical data. 4 Salem and Smith created a compartmental model of Ebola with a fifth compartment for the infectious deceased to model the dynamics of an Ebola outbreak in a village of 1000 people, and analyzed the disease-free equilibrium of the model. 5 Thomson showed that once EVD has infected a person, it will spread through broken skin or mucous membranes via direct contact, including through blood, secretions, organs, or other bodily fluids of infected people. 6 It has approximately the same transmission risk as the SARS virus. We calculated that EVD has a latency, and there is a lag after vaccine injection. In addition, we must take the medicine's effective cure rate into consideration. If we neglect the lag and latency, we cannot control the transmission risk of EVD efficiently. 7 In order to solve this problem, we built a SEIQR model to study the optimal control method for the transmission risk of Ebola, and analyzed the stability of the free-Ebola-virus-disease equilibrium and Ebola-virus-disease equilibrium.
However, the infectivity of Ebola is much higher than that of SARS, and, due to economic underdevelopment, the health system in West African countries is stunted. Conditions are not adequate to mass-produce EVD medicines in the affected countries; only the United States, Canada, and Japan can produce the drugs needed for treatment of Ebola at present. It is worthy to build a model to solve the transmission of therapeutic medication, including a feasible delivery system and locations of delivery.
Based on the above analysis, our purpose is to seek an effective method of controlling the transmission risk of EVD by building models. In order to find an effective method to control the transmission risk of EVD, we studied numerous academic references and some advanced models to support our assumptions. In the field of infectious disease transmission modeling, the SIR model is one of the simplest compartmental models, and many other models are derivations of this basic form. 8 The SIR model consists of three compartments -S for the number of susceptible individuals, I for the number of infectious individuals, and R for the number of recovered (or immune) individuals. 9 The SIR model is reasonably predictive for infectious diseases that are transmitted among humans, and where recovery confers lasting resistance, such as measles, mumps, and rubella. Therefore, we took individuals who were latently infected and isolated or quarantined individuals into consideration when using the basic SIR model to formulate simulations under different conditions. To solve the above problem, the key contribution of this paper is to establish a simulation model and optimal control method for the transmission risk of EVD. This rest of this paper is divided as follows. Section 2 outlines our assumptions. Section 3 analyzes the impact of effective controls on the transmission risk of Ebola on the basis of the SEIQR model. Section 4 formulates numerical simulations to obtain the SEIQR model's numerical solution. Section 5 uses the center-of-gravity method to obtain the location for medicine delivery. Section 6 uses the general discrete-time model to confirm that the theory of the optimal control rate has a negative effect on the transmission risk of EVD.
Assumptions
In order to build a SEIQR model 10 to study the optimal control method for the transmission risk of Ebola, we make some assumptions as follows.
(1) We ignore transmission from the production location to the epidemic area. 
Symbols in the SEIQR model
Notation used in the SEIQR model is defined in Table 1 . 
Terminology used in the SEIQR model

The effective control of the transmission risk of EVD
Researchers have obtained biological virus transmission dynamics results to guide control strategies. The classic model is the SIR model. 11 In this model, the crowd is divided into three groups: individuals who are susceptible to the disease; infected but not isolated individuals; and individuals that have recovered and are immune to the disease. 12 Feng and Thieme showed that the inclusion of an isolated class in the SIR model for childhood diseases can give rise to sustained oscillations. 13 Their model neglects the latency period, which can often be as long as or longer than the infectious period for childhood diseases. EVD also has a latency, so the SIR model cannot reflect the transmission risk of EVD.
After injecting with medicine, antibodies in the serum can mediate the immune cell's activity and promote phagocytosis, neutralizing toxins and pathogens, working against pathogens via pathogen-specific recognition. This period indicates that there exists a lag after injection with the vaccine. The SIR model neglects this lag. In addition, we have taken the medicine's effective cure rate into consideration. Thus, it is critical to introduce quarantine to the model when controlling the transmission risk of EVD.
Mishra and Saini analyzed a continuous SEIQRS model for the transmission of malicious objects. 14 Wu and Feng considered an SIQR model of childhood diseases. 15 Richard and Mark 16 proposed an improved SEI model to simulate virus propagation.
The above researchers analyzed several epidemic models in detail, but they did not introduce the influence of the lag and quarantine on the model at the same time. 17 Therefore, we built the SEIQR model to study the transmission risk of EVD and then analyze the stability of the free-Ebola-virus-disease equilibrium and the Ebola-virusdisease equilibrium.
Parameters
The SEIQR model's parameters are defined in Table 2 .
The establishment of EVD's SEIQR model
Mishra established a SARS mathematical model in accordance with the structure of the SEIQR model structure (Figure 1 ). 10 The equation of the SARS mathematical model shown in Figure 1 is as follows: Parameters Definitions
The number of individuals who are susceptible to the disease from t to t + 1 equivalent day 0 < β < 1
The average effective contact rate
The mortality rate of individuals who are susceptible to the disease, which is affected by non-disease factors 0 < μ < 1
The morbidity of the individuals who are latently infected 0 < δ < 1
The probability of the change from infected but without isolation individuals to isolated or quarantined individuals 0 < ε < 1
The recovery probability of the isolated or quarantined individuals 0 < η < 1
The secondary-infection probability of the recovered individuals 0 < γ < 1
The recovery probability of the infected but without isolation individuals 0 < α < 1
The mortality rate of the infected but without isolation individuals and isolated or quarantined individuals which is caused by the disease factor Comparing with the above continuous mathematical model, we found that the discrete-time virus model is better to satisfy the practical requirements, and it is more convenient to solve the stability conditions for these mathematical models.
Thus, we arrived at the conclusion that using the discrete-time mathematical model to describe the transmission dynamics of Ebola is more convincing. So after discretizing the continuous SEIQR model derived by Mishra and Jha, 10 we obtained an EVD SEIQR model as follows:
We used the SEIQR model with five conditions to represent the transmission risk of EVD. We let S t ð Þ, E t ð Þ, I t ð Þ, Q t ð Þ, and R t ð Þ be the values in the conditions of S, E, I, Q, and R in the t-th equivalent day respectively. The number of individuals who are susceptible to EVD in the t-th equivalent day is as follows:
Simulation and results analysis
Considering the system described in Equation (1), we supposed that the totals of S, E, I, Q, and R were regarded as 1. The percentages of S, E, I, Q, and R in the network are 0.9, 0.01, 0.01, 0.04, and 0.04 respectively when the corresponding coefficients are as follows: From the simulation results shown in Figures 2-4 , we can conclude that the percentages of individuals who are susceptible to EVD, individuals who are latently infected, infectious individuals, isolated or quarantined individuals, and the individuals that have recovered and are immune to EVD will be vanished at finite days.
This means that if we take effective control, using the EVD SEIQR model built in this article, EVD will be vanquished. If not, it will damage people's health. Therefore, we should obtain the necessary measurements to prevent and control the transmission risk of EVD.
The numerical simulation for the EVD SEIQR model
Researchers have explored the dynamics of biological virus transmission, and have strategies for control. They have concluded that the classic biological virus transmission model is the SIR model. But because it neglects latency and isolation effects, in this paper we introduce these elements and formulate a simulation for the transmission risk of EVD on the basis of the SEIQR model. The amount of the vaccine and drugs available for EVD is limited -there is not enough to cover the whole epidemic area. Also, medical institutions cannot confirm whether individuals who are susceptible to the disease are carriers.
Once the latency period is over, those who spend a long time in contact with carriers are susceptible to EVD (e.g., doctors, nurses, and other individuals who are in contact with EVD carriers). Therefore, in this paper we set the drop-point for delivery of the vaccine and drugs as the medical institution. In order to stabilize the number of rescuers, doctors, nurses, and other individuals who are in contact with EVD, they are injected with the vaccine. Meanwhile, the infectedwithout-isolation individuals need to be isolated immediately; they are also injected with the vaccine.
Assumptions
(1) We only consider therapeutic drugs to be delivered to isolated or quarantined individualsQ t ð Þ, neglecting infected-without-isolation individuals I t ð Þ. 
The construction of the medicine demand model
Due to
we obtained that
Then
the equation is as follows:
where m e represents the total demand for the medicine, v a represents the demand for the therapeutic drugs, d r represents the amount of vaccine, b represents the average effective contact rate, e represents the recovery probability of the isolated or quarantined individuals,
ð Þ represents the average amount of therapeutic drugs for isolated or quarantined individuals, k 1 represents the rate of nature immunity (k 1 . 0) and k 2 represents the medicine's effective cure rate.
The impact of EVD transmission on the demand for the medicine
We introduced sensitivity analysis into the medicine demand model to analyze the transmission risk of EVD, and obtained the sensitivity of the parameters related to the vaccine and therapeutic drugs. Parameter sensitivity analysis is a method from the linear programming model to find the optimum solution and target function values when a certain parameter or several parameters change. The basic principle of the single parameter sensitivity analysis is to set a fluctuation range for the parameter requiring sensitivity analysis. 18, 19 We assume that the other parameters do not change; only the parameter requiring sensitivity analysis changes. Based on the above assumption, we calculated the change of the parameter, then analyzed the target function to obtain the sensitivity of the parameter. Converting to the other parameters, we used the same method to analyze the impact on the target function that results from the change of the parameter, until all parameters are calculated. We compare the magnitude of the uncertain parameters' sensitivity coefficient, and present them in ascending order. Then we can conclude that the bigger the coefficient, the greater its influence on the efficiency of the target function. First, we built a system model as follows:
In this equation, F represents the target function, x 1 , x 2 , Á Á Á , x k , Á Á Á , x n are uncertain parameters that can affect the target function, and x k is the parameter awaiting sensitivity analysis.
After construction of the model, it is critical to give the basic set of parameters that is relied on in this discussion. We assumed the basic set of parameters to be x 1 , x 2 , Á Á Á , x k , Á Á Á , x n ; the character of the system performance is as follows:
With the basic set of parameters confirmed, we analyzed the sensitivity of each parameter. When analyzing the influence of parameters on the target function, we keep other parameters at their reference values, but allow parameter x k to fluctuate in its available range. Therefore, the sensitivity of parameter x k is as follows:
where DF represents the maximum value of the target function value when it deviates from the basic target function value. In other words, sensitivity can also be defined as the percentage of the change of the target function value when a certain input parameter changes:
Simulation and results analysis
In accordance with the above analysis, we obtained the tendency charts as shown in Figures 5-7 . From Figure 5 , we can see the correlation between the amount of vaccine needed and the number of individuals who are susceptible to EVD. When the amount of individuals who are susceptible increases, the amount of vaccine needed increases. This shows these factors are positively correlated.
From Figure 6 , we can see the correlation between amount of therapeutic drugs needed and the number of isolated or quarantined individuals. When the amount of isolated or quarantined individuals increases, so does the amount of therapeutic drugs needed. This also shows they are positively correlated.
In Figure 7 we have treated values of S, E, Q, and I as one unit. From the figure, we can see the correlation of the amount of medicine needed and S, E, Q, I, and how the proportion of medicine demanded descends to 2. This means the production speed of the vaccine and therapeutic drugs cannot keep pace with demand. This situation suggests that manufacturers should accelerate the speed of production, or the transmission risk of EVD will grow out of control.
The center-of-gravity method for determining the medicine delivery location
To obtain the best location for medicine delivery, we used the center-of-gravity method. We assumed that the medicine demand point and the medicine supply point constitute a logistics system in a certain planar range. The demand and supply for medicine can be regarded as the weight of the objects, and we can treat the gravity of the logistics system as the optimal location for delivery. We obtained the optimal location for delivery by calculating the gravity of the system, which is filled with objects.
Assumptions
(1) We only consider the epidemic area's demand for medicine. (2) The epidemic area's demand for medicine is proportional to the epidemic situation. (3) We ignore the border of the three countries. (4) We simplify the distance from the medicine supply point to the epidemic area, supposing it is a straight line. (5) The supply for medicine is sufficient. (6) We treat Conakry as the location of the epidemic's first outbreak.
Parameters
The center-of-gravity method's symbols are defined in Table 3 . The coordinate of different cities is as shown in Table 4 .
Determining the optimal location for medicine delivery
According to the center-of-gravity method, we treated both demand point and supply point as particles. The equivalent weight of the demand point is g i , and g i = c i w i . The equivalent weight of the supply point is G, and G = P n i = 1 g i . Figure 7 . The tendency chart of the total amount of the medicine and S, E, Q, I. Table 3 . Center-of-gravity method notation.
Signs Definitions i
The epidemic area M The total capacity a i
The epidemic area's x-axis relatively to the origin coordinate b i
The epidemic area's y-axis relatively to the origin coordinate
The supply point's x-axis relatively to the origin coordinate in the left y i
The supply point's y-axis relatively to the origin coordinate in the right c ij
The practical amount of the medicine supply e
The amount of the stored medicine d i
The demand for the medicine in each epidemic area In accordance with the characteristics of gravity, we obtained the following:
where d 0 represents the distance from the supply point to the origin coordinate. The sum of all torques on the x-axis and y-axis, which is rooted from each particle, can be written as follows:
Then, we obtained the optimal coordinate of the location for medicine delivery: Based on the analysis above, we obtained the final model as follows:
From the above data, we can easily see that the objective function is the most optimistically expected time to reach all those infected individuals expressed as a function of the assignment of number to the medicine supply points. In Equation (12) , the equality constraints ensure that the medicine equals the demand, and the inequality constraints ensure that the supply is enough. We used Lingo to solve this optimization problem.
When there was only one delivery point, we obtained the optimal coordinate of the location for medicine delivery as shown in Figure 8 .
The optimal solution is 11443 and the optimal coordinate is (289.9, 2158), near Kemena.
When there were two delivery points, we obtained the optimal coordinates of the location for medicine delivery as shown in Figure 9 .
The optimal solution is 7280.28 and the optimal coordinates are (374.68,2206) and (80,236), which are near Lofa and Kambla.
When there were three delivery points, we obtained the optimal coordinates of the location for medicine delivery as shown in Figure 10 . The optimal solution is 6595.6 and the optimal coordinates are (378, 2207), (20, 30), and (97, 280), which are near Lofa, Dubreka, and Port Loko.
From the above solutions, we can conclude that when the number of medicine delivery points increase, the optimal solution decreases from 11443 to 6595. If we can set only one delivery point, we can set Kenema as the optimal location. If we can set two delivery points, we can set Lofa and Kambla as the optimal locations. And if we can set three delivery points, we can set Lofa, Dubreka, and Port Loko as the optimal location.
In the above situation, we can send medicine to the epidemic area within the shortest time, which will help to control the transmission risk of EVD.
6. The general discrete-time model 6.1 Constructing the optimal control rate for the EVD model
Based on the above optimal EVD model, we introduced the control rate. By using the discrete-time virus model's optimal control rate to control the serious transmission risk of Ebola virus in the crowd, we added an effective strategy for transmission to the model, meaning the supply of vaccine and therapeutic drug increased, and the amount of infected-without-isolation individuals and isolated or quarantined individuals is much smaller than the individuals who are susceptible to EVD. The control sheet for the optimal control rate is as follows:
where t is a constant in which t . 0, c t ð Þ represents the element of control and its realistic meaning is that, after obtaining the optimal routine for the system of medicine delivery, the medicine delivery become much quicker, so the number of individuals who are susceptible to EVD and isolated or quarantined individuals falls. So the effect of c t ð Þ is to control the amount of individuals who are susceptible to EVD, and isolated or quarantined individuals.
From the above analysis, we obtained the general discrete-time model as follows:
ð Þ
where M represents the total capacity, in which M f is the reciprocal of M, so the optimal routine's total capacity is as follows:
where M 1 represents the optimal routine's total capacity when there is only one delivery point; M 2 represents the optimal routine's total capacity when there are two delivery points; and M 3 represents the optimal routine's total capacity when there are three delivery points.
Simulation and results analysis
Considering the system described by Equation (1) After adding the control rate to the model, we obtain the simulation curves of E, I, shown in Figure 11 .
Comparing Figure 11 with Figure 2 , we can see that the amount of individuals who are latently infected and the infected-without-isolation individuals fall to zero in a Figure 10 . The optimal coordinates for three delivery points.
shorter period of time. So we can conclude that the theory of the optimal control rate has reduces the transmission risk of EVD.
The above study shows that EVD's SEIQR model is useful for predicting the transmission risk of Ebola, and we can obtain effective measures to prevent or reduce the risk of EVD to patients by formulating numerical simulations in the SEIQR model. In the SEIQR model built in this paper, the medicine is divided into drugs and vaccine, so we can analyze the transmission tendency of the EVD more accurately, and drug manufacturers can use the SEIQR model to predict the demand for medicine.
Stability analysis of the SEIQR model
From the above analysis, the EVD's SEIQR model obtained is as follows:
The initial conditions for Equation (1) are given as follows: In order to calculate the equilibrium of Equation (1), we let the following: 
We calculated the Ebola-virus-disease equilibrium by solving Equation (3); then we obtained Equation (20): e e = S e , E e , I e , Q e , R e ð Þ ð 20Þ
where Figure 11 . The simulation curves of E and I.
